Chronic rhinosinusitis without nasal polyps
CRSsNP · Immunology · 1 drugs · 1 indications
Competitive Landscape (1 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Itepekimab | REGN | IL-33 inhibitor | Monoclonal antibody | SC | PHASE3 |
Indications (1)
Chronic rhinosinusitis without nasal polyps
Upcoming Catalysts
Itepekimab - COPD - Ph3 Topline (AERIFY)CLINICAL
REGN2026-2027
Data from Supabase · Updated 2026-03-24